In the present work, we observed that Anamu-SC reduces glucose consumption in tumor cells (Figure 2), but this apparently has no effect on the population of T cells producing IFNγ and TNFα, although it does reduce the frequency of T cells producing IL-2 (Figure 6). Here, IL2 is linked to neoplasm.